HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Steven G Davis Selected Research

gimsilumab

1/2022Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Steven G Davis Research Topics

Disease

1COVID-19
01/2022
1Hypoxia (Hypoxemia)
01/2022
1Inflammation (Inflammations)
01/2022
1Pneumonia (Pneumonitis)
01/2022
1Blindness (Hysterical Blindness)
12/2007

Drug/Important Bio-Agent (IBA)

1gimsilumabIBA
01/2022
1Monoclonal AntibodiesIBA
01/2022
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2022
1DNA PrimersIBA
12/2007

Therapy/Procedure

1Therapeutics
01/2022